These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14971844)

  • 21. [Time for a European perspective on cardiovascular prevention].
    Nilsson PM; Perk J; Rydén L
    Lakartidningen; 2008 Apr 2-8; 105(14):1000-4. PubMed ID: 18478749
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cardiovascular risk evaluation in three exposed populations].
    Mazigh C; Nsiri B; Ghazouani E; Ben Khelifa H; Aouni Z; Azzouzi F; Zidi B; Machghoul S; Gueddiche M
    Tunis Med; 1999 Jan; 77(1):19-22. PubMed ID: 10333692
    [No Abstract]   [Full Text] [Related]  

  • 23. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
    Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [When should we start the treatment of the cardiovascular risk factors].
    de Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2008; 125(1):125-36; discussion 136-44. PubMed ID: 18777847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal and childhood onset of adult cardiovascular diseases.
    Cohen MS
    Pediatr Clin North Am; 2004 Dec; 51(6):1697-719, x. PubMed ID: 15561181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection programme for diabetes mellitus type 2 in the Czech Republic--initial results].
    Perusicová J
    Vnitr Lek; 2001 Mar; 47(3):134-9. PubMed ID: 15635873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mobile screening programme for the cardiovascular and microvascular complications of Type 2 diabetes in primary care.
    Sampson MJ; Barrie P; Dozio N; Flatman M; Hadley-Brown M; Harvey I; Heyburn PJ; Jones C; Mann R; Temple RC; Greenwood RH
    Diabet Med; 2005 Mar; 22(3):256-7. PubMed ID: 15717871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential cardiovascular benefits of insulin sensitizers.
    Kunhiraman BP; Jawa A; Fonseca VA
    Endocrinol Metab Clin North Am; 2005 Mar; 34(1):117-35. PubMed ID: 15752925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of cardiovascular risk factors by anthropometric measures in Tehranian adults: receiver operating characteristic (ROC) curve analysis.
    Mirmiran P; Esmaillzadeh A; Azizi F
    Eur J Clin Nutr; 2004 Aug; 58(8):1110-8. PubMed ID: 15280905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for type 2 diabetes in adults: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am Fam Physician; 2003 May; 67(10):2177-80. PubMed ID: 12776968
    [No Abstract]   [Full Text] [Related]  

  • 31. For aggressive preventive management of type 2 diabetes. What is the evidence and is it enough?
    Genuth S
    J Fam Pract; 1998 Nov; 47(5 Suppl):S23-6. PubMed ID: 9834751
    [No Abstract]   [Full Text] [Related]  

  • 32. New insights into understanding cardiometabolic risk. Introduction.
    Fonarow GC; Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: factors influencing on international application of evidence-based guidelines.
    Hayashino Y; Shimbo T; Tsujii S; Ishii H; Kondo H; Nakamura T; Nagata-Kobayashi S; Fukui T
    Int J Cardiol; 2007 May; 118(1):88-96. PubMed ID: 16949690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of cardiovascular mortality in type-2 diabetes by aggressive and early intervention strategies.
    Schernthaner G
    Wien Klin Wochenschr; 1999 Jan; 111(2):43-5. PubMed ID: 10081120
    [No Abstract]   [Full Text] [Related]  

  • 35. Increased arterial stiffness is associated with reduced plasma levels of beta-carotene in treated hypertensive patients with type 2 diabetes mellitus.
    Chung HK; Kang B; Lee JH; Shim JY; Park S; Lee SH; Park YK; Park E; Chung N; Shin MJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):e9-e11. PubMed ID: 19505810
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experiences of family physicians participating in the first governmental financed health screening program in Hungary].
    Rurik I; Killik M; Székely A
    Orv Hetil; 2006 Dec; 147(52):2507-13. PubMed ID: 17294575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of hypertension in elderly patients with multiple morbidity].
    Slany J
    Wien Med Wochenschr; 2004; 154 Spec No 1(1):4-6. PubMed ID: 15346545
    [No Abstract]   [Full Text] [Related]  

  • 38. [Increased risk of cardiovascular diseases and diabetes in mentally ill persons. Life style is a contributing factor].
    Attvall S; Eliasson B; Nilsson P
    Lakartidningen; 2003 Jul; 100(28-29):2353-5. PubMed ID: 12899026
    [No Abstract]   [Full Text] [Related]  

  • 39. Do different vascular risk factors affect all arteries equally?
    Paraskevas KI; Bessias N; Papas TT; Gekas CD; Andrikopoulos V; Mikhailidis DP
    Angiology; 2008; 59(4):397-401. PubMed ID: 18505745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic nephropathy: implications for renal and cardiovascular outcomes.
    Folan LA; Tuttle KR
    Minerva Med; 2004 Oct; 95(5):385-94. PubMed ID: 15467514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.